2020-12-30,Concert Pharmaceuticals Could Rally in 2021
2020-12-17,Is CNCE A Good Stock To Buy Now?
2020-12-16,"How Much Of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Do Insiders Own?"
2020-11-09,Concert Pharmaceuticals to Present at Upcoming Investor Conferences
2020-11-06,"Concert Pharmaceuticals, Inc. (CNCE) Q3 2020 Earnings Call Transcript"
2020-11-05,"Concert Pharmaceuticals, Inc. to Host Earnings Call"
2020-11-05,Concert Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Company Update
2020-11-03,Concert Pharmaceuticals Initiates THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata
2020-11-01,"If You Had Bought Concert Pharmaceuticals (NASDAQ:CNCE) Stock A Year Ago, You Could Pocket A 59% Gain Today"
2020-10-29,Concert Pharmaceuticals Presents CTP-543 Data from Long-Term Extension Study in Alopecia Areata During Late-Breaking Session at EADV Congress
2020-10-29,"Concert Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020"
2020-10-22,Concert Pharmaceuticals Announces Publication on Alopecia Areata Burden of Disease in Journal of Investigative Dermatology
2020-10-13,Concert Pharmaceuticals Announces CTP-543 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2020 EADV Virtual Congress
2020-09-29,Concert Pharmaceuticals Completes Enrollment in CTP-692 Phase 2 Trial in Patients with Schizophrenia
2020-09-08,Concert Pharmaceuticals to Present at Upcoming Investor Conferences
2020-08-18,Concert Pharmaceuticals to Present at The JMP Securities CNS Forum
2020-08-12,How Does Concert Pharmaceuticals' (NASDAQ:CNCE) CEO Salary Compare to Peers?
2020-08-06,"Concert Pharmaceuticals (CNCE) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-06,Concert Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Company Update
2020-07-30,Will Concert Pharmaceuticals (CNCE) Report Negative Q2 Earnings? What You Should Know
2020-07-30,"Concert Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 6, 2020"
2020-07-08,Concert Pharmaceuticals Receives FDA Breakthrough Therapy Designation for CTP-543 for the Treatment of Alopecia Areata
2020-07-06,"Need To Know: Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Insiders Have Been Buying Shares"
2020-07-06,Hedge Fund Sentiment Is Stagnant On Concert Pharmaceuticals Inc (CNCE)
2020-06-30,Concert (CNCE) Upgraded to Buy: Here's Why
2020-06-30,Is Concert Pharmaceuticals (CNCE) Stock Outpacing Its Medical Peers This Year?
2020-06-24,Insider Sells Concert Pharmaceuticals' Shares
2020-06-12,Concert Pharmaceuticals Releases Additional Data from Phase 2 Clinical Trial of CTP-543 in Alopecia Areata
2020-05-26,Concert Pharmaceuticals to Webcast Fireside Chat at Jefferies Virtual Global Healthcare Conference
2020-05-22,How Concert Pharmaceuticals (CNCE) Stock Stands Out in a Strong Industry
2020-05-12,Edited Transcript of CNCE earnings conference call or presentation 30-Apr-20 12:30pm GMT
2020-05-12,Concert Pharmaceuticals to Webcast Presentation at UBS Virtual Healthcare Conference
2020-05-01,"Concert Pharmaceuticals, Inc. (CNCE) Q1 2020 Earnings Call Transcript"
2020-04-30,"Concert Pharmaceuticals (CNCE) Reports Q1 Loss, Lags Revenue Estimates"
2020-04-30,Concert Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Update on Clinical Programs
2020-04-29,Concert (CNCE) Moves to Buy: Rationale Behind the Upgrade
2020-04-23,"Concert Pharmaceuticals to Report First Quarter 2020 Financial Results on April 30, 2020"
2020-04-15,Why Concert Pharmaceuticals (CNCE) Stock Might be a Great Pick
2020-04-01,Concert Pharmaceuticals Announces Plans for CTP-543 Phase 3 Trials in Alopecia Areata
2020-03-26,Some Concert Pharmaceuticals (NASDAQ:CNCE) Shareholders Are Down 47%
2020-03-12,Edited Transcript of CNCE earnings conference call or presentation 27-Feb-20 1:30pm GMT
2020-02-24,Concert Pharmaceuticals Selected for Late-Breaking Oral Presentation of CTP-543 Phase 2 Data in Alopecia Areata at the 2020 American Academy of Dermatology Annual Meeting
2020-02-20,"Concert Pharmaceuticals to Report Full Year 2019 Results on February 27, 2020"
2020-01-30,Concert Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-01-28,Concert Pharmaceuticals Announces Pricing of Public Offering
2020-01-27,Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock
2020-01-27,Concert Pharmaceuticals Announces Federal Circuit Granted its Motion to Vacate and Remand PTAB Decision Involving CTP-543
2020-01-24,"Should You Be Concerned About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) Historical Volatility?"
2020-01-22,"Concert Pharmaceuticals Announces Notice of Allowance for U.S. Patent Application Related to CTP-543, Lead Candidate for Treatment of Alopecia Areata"
2019-12-19,Concert Pharmaceuticals Successfully Completes Open Label Trial of CTP-543 in Patients with Alopecia Areata
2019-12-16,We Think Concert Pharmaceuticals (NASDAQ:CNCE) Needs To Drive Business Growth Carefully
2019-12-13,Do Hedge Funds Love Concert Pharmaceuticals  Inc (CNCE)?
2019-12-02,Concert Pharmaceuticals Initiates CTP-692 Phase 2 Trial in Schizophrenia
2019-11-25,Edited Transcript of CNCE earnings conference call or presentation 7-Nov-19 1:30pm GMT
2019-11-12,Concert Pharmaceuticals to Present at Upcoming Investor Conferences
2019-11-10,"Should You Worry About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) CEO Salary Level?"
2019-11-07,"Concert Pharmaceuticals (CNCE) Reports Q3 Loss, Misses Revenue Estimates"
2019-11-07,Concert Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Company Update
2019-11-06,Concert Pharmaceuticals to Host KOL Webcast Event Focused on CTP-692 and Schizophrenia
2019-11-05,Concert Pharmaceuticals  Inc (CNCE) Is Burning These Hedge Funds
2019-10-31,Analysts Estimate Concert Pharmaceuticals (CNCE) to Report a Decline in Earnings: What to Look Out for
2019-10-31,"Concert Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 7, 2019"
2019-10-12,Concert Pharmaceuticals Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at EADV Congress
2019-10-02,Concert Pharmaceuticals to Provide Overview of Clinical Pipeline at Cantor Healthcare Conference
2019-09-27,Concert stock falls 36 percent on Alzheimer's drug trial failure
2019-09-23,Concert Pharmaceuticals Names Jeffrey Munsie as Chief Legal Officer
2019-09-19,Did You Manage To Avoid Concert Pharmaceuticals's (NASDAQ:CNCE) 20% Share Price Drop?
2019-09-17,Concert Pharmaceuticals Completes Enrollment in Second Open Label Trial of CTP-543 to Evaluate Once-Daily vs. Twice-Daily Dosing in Patients with Alopecia Areata
2019-09-12,Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2019 EADV Congress
2019-08-29,Concert Pharmaceuticals to Present at Upcoming Investor Conferences
2019-08-27,Edited Transcript of CNCE earnings conference call or presentation 1-Aug-19 12:30pm GMT
2019-08-16,"What You Must Know About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) Beta Value"
2019-08-06,"Concert Pharmaceuticals, Inc. (CNCE) Q2 2019 Earnings Call Transcript"
2019-08-01,"Concert Pharmaceuticals (CNCE) Reports Q2 Loss, Misses Revenue Estimates"
2019-07-25,"Concert Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 1, 2019"
2019-07-05,"Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Insiders Increased Their Holdings"
2019-06-13,Concert Pharma's CTP-692 Positive for Schizophrenia in Phase I
2019-06-12,Concert Pharmaceuticals Reports Positive Results from Phase 1 Studies Evaluating CTP-692 in Healthy Volunteers
2019-06-05,Concert Pharmaceuticals Completes Enrollment in Open Label Trial to Evaluate Once-Daily vs. Twice-Daily Dosing of CTP-543 in Patients with Alopecia Areata
2019-05-28,Edited Transcript of CNCE earnings conference call or presentation 2-May-19 12:30pm GMT
2019-05-16,Concert Pharmaceuticals Announces Initiation of New Open Label Trial to Evaluate Once-Daily vs. Twice-Daily Dosing of CTP-543 in Patients with Alopecia Areata
2019-05-14,Concert Pharmaceuticals to Present at Upcoming Investor Conferences
2019-05-07,"Why Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) CEO Pay Matters To You"
2019-05-02,"Concert Pharmaceuticals, Inc. (CNCE) Q1 2019 Earnings Call Transcript"
2019-05-02,Concert: 1Q Earnings Snapshot
2019-05-02,Concert Pharmaceuticals Reports First Quarter 2019 Financial Results
2019-04-29,Concert Pharmaceuticals Names Jesper HÃ¸iland to its Board of Directors
2019-04-25,Earnings Preview: Concert Pharmaceuticals (CNCE) Q1 Earnings Expected to Decline
2019-04-25,"Concert Pharmaceuticals to Report First Quarter 2019 Financial Results on May 2, 2019"
2019-04-11,Concert Pharma Initiates Early-Stage Schizophrenia Study
2019-04-11,Concert Pharmaceuticals to Present CTP-543 Phase 2 Interim Data in Alopecia Areata at 2019 World Congress for Hair Research Annual Meeting
2019-04-10,Concert Pharmaceuticals Initiates Phase 1 Multiple-Ascending Dose Trial of CTP-692 as an Adjunctive Treatment for Schizophrenia
2019-04-08,Concert Pharmaceuticals' stock takes a sharp dive after disappointing patent appeal board ruling
2019-04-08,Concert Pharmaceuticals Announces Decision from Patent Trial and Appeal Board in IPR Proceeding
2019-03-25,New Strong Sell Stocks for March 25th
2019-03-12,New Strong Sell Stocks for March 12th
2019-03-12,Concert Pharmaceuticals to Present at Upcoming Oppenheimer Healthcare Conference
2019-03-07,Vertex's VX-445 Triple Combo Cystic Fibrosis Trials Succeed
2019-03-06,Concert Pharmaceuticals Announces Initiation of Open Label Trial to Evaluate Once-Daily vs. Twice-Daily Dosing of CTP-543 in Patients with Alopecia Areata
2019-03-05,Edited Transcript of CNCE earnings conference call or presentation 28-Feb-19 1:30pm GMT
